| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |